Low-cost polypill could dramatically cut heart attacks, strokesA single tablet that contains four generically-available drugs – or ‘polypill’ – could offer an effective, low-cost way Share XLow-cost polypill could dramatically cut heart attacks, strokeshttps://pharmaphorum.com/news/low-cost-polypill-could-dramatically-cut-heart-attacks-strokes/
GW confident epilepsy drug will get NHS funding despite NICE rejectionThe UK’s GW Pharma has insisted there will be no repeat of the controversy seen with cystic fibrosis Share XGW confident epilepsy drug will get NHS funding despite NICE rejectionhttps://pharmaphorum.com/news/no-repeat-of/
AZ buys cut price priority review voucher, but for what?AstraZeneca has bought a priority review voucher (PRV) from Swedish biotech Sobi for $95 million, but isn’t revealing Share XAZ buys cut price priority review voucher, but for what?https://pharmaphorum.com/news/az-buys-cut-price-priority-review-voucher-but-for-what/
Listening to the patient voice: Why developing new dementia treatments is everyone’s jobDeveloping life-changing treatments for dementia is a team effort that takes commitment from all involved, from charities and Share XListening to the patient voice: Why developing new dementia treatments is everyone’s jobhttps://pharmaphorum.com/views-and-analysis/listening-to-the-patient-voice-why-developing-new-dementia-treatments-is-everyones-job/
NICE’s track record in cancer drugs: the impact of the CDF and interim fundingLeela Barham looks back to before the Cancer Drugs Fund and how recommendations have changed through CDF 1.0 Share XNICE’s track record in cancer drugs: the impact of the CDF and interim fundinghttps://pharmaphorum.com/views-and-analysis/nices-track-record-in-cancer-drugs-the-impact-of-the-cdf-and-interim-funding/
Getting patients round the virtual tableIf pharma wants to be truly patient-centric, it needs to be talking to patients. This may seem obvious, Share XGetting patients round the virtual tablehttps://deep-dive.pharmaphorum.com/magazine/oncology-asco-2019/impetus-digital-patient-centric-engagement/
Smarter thinking about pharmaceutical marketingRobb DeFilippis, from end-to-end global creative production and sourcing partner Tag, discusses how a more effective multichannel pharma Share XSmarter thinking about pharmaceutical marketinghttps://deep-dive.pharmaphorum.com/magazine/oncology-asco-2019/tag-pharmaceutical-marketing-production/
Getting patients round the virtual tableIf pharma wants to be truly patient-centric, it needs to be talking to patients. This may seem obvious, Share XGetting patients round the virtual tablehttps://deep-dive.pharmaphorum.com/magazine/oncology-asco-2019/impetus-digital-patient-centric-engagement/
Revealing the true value of new cancer drugs to payersMarc Botteman and Ben van Hout from Pharmerit International discuss how to navigate the value challenges of new Share XRevealing the true value of new cancer drugs to payershttps://deep-dive.pharmaphorum.com/magazine/oncology-asco-2019/pharmerit-cancer-drug-value-payers/
Innovative contracting in Europe – a Trojan horse? Share XInnovative contracting in Europe – a Trojan horse?https://pharmaphorum.com/market-access-2/innovative-contracting-in-europe-a-trojan-horse/
How pharma marketing can stay ahead of the evolving customer journey Share XHow pharma marketing can stay ahead of the evolving customer journeyhttps://pharmaphorum.com/digital/how-pharma-marketing-can-stay-ahead-of-the-evolving-customer-journey/
Launch excellence in a disrupted world – challenges & opportunities Share XLaunch excellence in a disrupted world – challenges & opportunitieshttps://pharmaphorum.com/market-access-2/launch-excellence-in-a-disrupted-world-challenges-opportunities/
Tell us: how fast is pharma innovatingpharmaphorum is conducting some research into how pharmaceutical marketers are innovating amidst the increasing demands of engaging in Share XTell us: how fast is pharma innovatinghttps://pharmaphorum.com/sales-marketing/tell-us-how-fast-is-pharma-innovating/
How to optimise pharma’s digital HCP engagementPharmaceutical companies face a ‘digital imperative’ to engage with healthcare professionals through their preferred mix of channels if Share XHow to optimise pharma’s digital HCP engagementhttps://pharmaphorum.com/debates-insight-sales-marketing/how-to-optimise-pharmas-digital-hcp-engagement/
A blueprint for healthcare: Brand strategy and planningWhen pharmaceutical and biotech companies are working on their brand strategy and conducting brand planning it is vital Share XA blueprint for healthcare: Brand strategy and planninghttps://pharmaphorum.com/sales-marketing/a-blueprint-for-healthcare-brand-strategy-and-planning/
AstraZeneca and lung cancer: the pharmaphorum podcast Share XAstraZeneca and lung cancer: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/astrazeneca-and-lung-cancer
Lung cancer’s patient information gap: the pharmaphorum podcast Share XLung cancer’s patient information gap: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/lung-cancers-patient-information-gap
ASCO 2019 – Kantar considers MacroGenics’ phase 3 SOPHIA trial Share XASCO 2019 – Kantar considers MacroGenics’ phase 3 SOPHIA trialhttps://pharmaphorum.com/spotlight/asco-2019-and-the-future-of-oncology/kantar-macrogenics-phase-3-sophia-trial/
Four Key Reasons to Attend SMi’s 2019 Biosimilars Conference Share XFour Key Reasons to Attend SMi’s 2019 Biosimilars Conferencehttps://pharmaphorum.com/partner-content/four-key-reasons-to-attend-smis-2019-biosimilars-conference/
Regulatory and Policy Keynote Sessions to be Delivered at the Wearable Injectors Share XRegulatory and Policy Keynote Sessions to be Delivered at the Wearable Injectorshttps://pharmaphorum.com/partner-content/regulatory-and-policy-keynote-sessions-to-be-delivered-at-the-wearable-injectors/
Registration is now open for the Pre-filled Syringes and Injectable devices Conference Share XRegistration is now open for the Pre-filled Syringes and Injectable devices Conferencehttps://pharmaphorum.com/partner-content/registration-is-now-open-for-the-pre-filled-syringes-and-injectable-devices-conference/
NICOX discusses New Glaucoma Treatment at SMi’s 3rd Ophthalmic Drugs Conference Share XNICOX discusses New Glaucoma Treatment at SMi’s 3rd Ophthalmic Drugs Conferencehttps://pharmaphorum.com/partner-content/nicox-discusses-new-glaucoma-treatment-at-smis-3rd-ophthalmic-drugs-conference/
Ashfield Commercial and Patient Solutions appoints President of Global Business Development Share XAshfield Commercial and Patient Solutions appoints President of Global Business Developmenthttps://pharmaphorum.com/partner-content/ashfield-commercial-and-patient-solutions-appoints-president-of-global-business-development/
Alice Choi appointed HCA chairperson Share XAlice Choi appointed HCA chairpersonhttps://pharmaphorum.com/news/alice-choi-hca-chairperson/
